製品名
モノクロナール抗ヒトIgG3−ビオチン マウス宿主抗体, clone HP-6050, purified from hybridoma cell culture
biological source
mouse
conjugate
biotin conjugate
antibody form
purified from hybridoma cell culture
antibody product type
secondary antibodies
clone
HP-6050, monoclonal
form
buffered aqueous solution
species reactivity
human
technique(s)
direct ELISA: 1:40,000
isotype
IgG1
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
類似した製品をお探しですか? 訪問 製品比較ガイド
関連するカテゴリー
Biochem/physiol Actions
本抗体は、ヒトIgG3に特異的であり、他のIgGサブクラスには反応しません。このクローンは、その特異性と反応性から、IUIS/WHOの研究によって幅広いアッセイプロトコールやテクニックへの応用が推奨されています。
IgG antibody subtype is the most abundant of serum immunoglobulins of the immune system. It is secreted by B cells and is found in blood and extracellular fluids and provides protection from infections caused by bacteria, fungi and viruses. Maternal IgG is transferred to fetus through the placenta that is vital for immune defense of the neonate against infections. The coupling of biotin to monoclonal Anti-Human IgG3 antibody allows for the binding of various labels such as avidin or streptavidin.
Only IgG1 and IgG3 are capable of adherence to mononuclear phagocytes. IgG3 has O-glycosylation sites and mediates, phagocytosis, antibody-mediated cellular cytotoxicity, neutralization, and activates complement pathways. IgG3 subtypes have short in vivo half-life and mediates the effector functions than IgG1.
Physical form
0.01 M PBS溶液(pH 7.4, 1% BSA, 15 mMアジ化ナトリウム含有)
Application
The product may be used for the identification of human IgG3 subclass by means of various immunoassays and ELISA. It has also been used in immunoblotting.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Human IgG consists of four subclasses (1-4) that can be recognized by antigenic differences in their heavy chains. They constitute approximately 65, 30, 5 and 4% of the total IgG, respectively. Each subclass has different biological and physicochemical properties. The IgG subclass may be preferentially produced in response to different antigens and pathological conditions. For instance, anti-polysaccharide responses are mainly of the IgG2 subclass while protein antigens give rise to IgG1 and IgG3 antibodies.
Monoclonal Anti-Human IgG3 (mouse IgG1 isotype) is derived from the hybridoma (HP-60501) produced by the fusion of mouse myeloma cells and splenocytes from an immunized mouse.
Immunogen
Purified myeloma human IgG3 coupled to polyaminostyrene (PAS) microbeads was used as the immunogen
Preparation Note
For continuous use, store at 2-8°C for up to one month. For extended storage, the solution may be frozen in working aliquots. Repeated freezing and thawing, or storage in "frost-free" freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify by centrifugation before use.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome
Bien, CG, et al.
European Journal of Neurology, 24(1), 175-186 (2017)
Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice
Braster R, et al.
PLoS ONE, 12(5), e0177736-e0177736 (2017)
Carolin Cornelius et al.
EBioMedicine, 11, 58-67 (2016-08-29)
We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen allergy, BM32, which is based on fusion proteins consisting of peptides from the IgE binding sites of the major grass pollen allergens fused to preS (preS1+preS2), a domain
Role of IgG3 in Infectious Diseases
Damelang T, et al.
Trends in Immunology, 40(3), 197-211 (2019)
A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-?IIb?3 autoantibodies
Akuta, K, et al.
Journal of Thrombosis and Haemostasis, 17(1), 206-219 (2019)
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)